Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Use of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML)

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00257647
First received: November 22, 2005
Last updated: February 17, 2009
Last verified: April 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2007
  Estimated Primary Completion Date: No date given